Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Kitcheetahon Oct 02, 2016 1:18pm

194 Views

Post# 25299862

HC approval process

HC has an 84 day approval process for class 3 medical devices, this is on their own website. If im not mistaken this is what was applied for as of the June kereport. Now if HC is a few weeks behind we may not hear back till November sometime. Aug, Sept, Oct +2 weeks. We obviously didn't get the fast track for the 30 days. Just be patient it will come.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?